Oral tolerance.
Faria AM, Weiner HL.
Immunol Rev. 2005 Aug;206:232-59. doi: 10.1111/j.0105-2896.2005.00280.x.
Contact tolerance.
Steinbrink K, Pior J, Vogl T, Sorg C, Macher E.
Pathobiology. 1999;67(5-6):311-3. doi: 10.1159/000028087.
Mechanisms of oral tolerance.
Garside P, Mowat AM.
Crit Rev Immunol. 1997;17(2):119-37. doi: 10.1615/critrevimmunol.v17.i2.10.
Ionizing radiation and the immune response.
Anderson RE, Warner NL.
Adv Immunol. 1976;24:215-335. doi: 10.1016/s0065-2776(08)60331-4.
Oral tolerance: therapeutic implications for autoimmune diseases.
Faria AM, Weiner HL.
Clin Dev Immunol. 2006 Jun-Dec;13(2-4):143-57. doi: 10.1080/17402520600876804.
Tolerance during dosing with H2-receptor antagonists. An overview.
Wilder-Smith CH, Merki HS.
Scand J Gastroenterol Suppl. 1992;193:14-9. doi: 10.3109/00365529209096000.
Defective Central Immune Tolerance Induced by High-Dose D-Galactose Resembles Aging.
Du HM, Wang YJ, Liu X, Wang SL, Wu SM, Yuan Z, Zhu XK.
Biochemistry (Mosc). 2019 Jun;84(6):617-626. doi: 10.1134/S000629791906004X.
Studies on the mechanism of action of the bipyridine milrinone on the heart.
Farah AE, Frangakis CJ.
Basic Res Cardiol. 1989;84 Suppl 1:85-103. doi: 10.1007/BF02650349.
Tissue levels of glyceryl trinitrate and cGMP after in vivo administration in rat, and the effect of tolerance development.
Torfgård K, Ahlner J, Axelsson KL, Norlander B, Bertler A.
Can J Physiol Pharmacol. 1991 Sep;69(9):1257-61. doi: 10.1139/y91-184.
The beginning of clinical tolerance in solid organ allografts.
Monaco AP.
Exp Clin Transplant. 2004 Jun;2(1):153-61.
